Clinical Trial Update: The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing two intravenous lipid emulsions in preterm infants with neonatal sepsis, reporting on outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis

Drugs mentioned

• lipid emulsion A
• lipid emulsion B

Snippet

Sponsor: Mansoura University Children Hospital | Conditions: Sepsis Newborn | Phase 4 | Status: COMPLETED